Prof. Mao Ying, MD, PhD
President, Huashan Hospital, Fudan University · Leader, Chinese Glioma Cooperative Group (CGCG)
Prof. Mao Ying
Director, Fudan Neurosurgical Institute
-
Hospital AffiliationHuashan Hospital, Fudan Univ.
-
Campus LocationHongqiao International Campus
-
Clinical LanguagesEnglish · Mandarin
-
Annual Case Volume1,200+ Complex Craniotomies
-
Consultation Turnaround24–48 Hours Priority Review
Pioneering Brain Functional Preservation in Modern Neuro-Oncology
Professor Mao Ying serves as President of Huashan Hospital, affiliated with Fudan University, and Chairman of the Chinese Glioma Cooperative Group (CGCG). Internationally acclaimed for pioneering high-field intraoperative MRI and awake functional brain mapping, he leads China's highest-volume neurosurgical department, conducting over 18,000 surgical procedures per year.
His research and surgical innovations focus on resolving the fundamental dilemma of neuro-oncology: achieving maximal safe resection of malignant brain tumors (GBM, anaplastic astrocytomas, oligodendrogliomas) while rigorously protecting motor, speech, and executive cognitive pathways in eloquent brain regions.
Core Clinical Expertise & Surgical Mastery
Structured clinical capabilities established through over 8,000 published neurosurgical interventions.
Intraoperative 3.0T MRI Craniotomy
Utilizes high-field intraoperative 3.0T MRI suites to rescan the brain in real time during resection, overcoming brain shift and maximizing tumor clearance while guarding vital tracts.
Awake Functional Cortical Mapping
Direct cortical and subcortical electrical stimulation during awake craniotomies precisely defines language, memory, and motor boundaries, safeguarding patient functional cognition.
Complex Skull Base & Insular Resection
Precision microsurgery for deep insular gliomas, petroclival meningiomas, and brainstem lesions deemed inoperable elsewhere, utilizing multimodal safe entry zone anatomy.
Multidisciplinary MDT Tumor Board
Leads Huashan's integrated neuro-oncology tumor boards, combining molecular NGS profiling, targeted adjuvant clinical trials, stereotactic CyberKnife, and TTFields therapy.
Consultation Sessions & Virtual MDT Triage
Landmark Academic Recognition & Impact
National Science and Technology Progress Award (2nd Class)
Recognized for clinical implementation of brain functional remodeling and intraoperative navigation systems.
Wu Jieping Medical Innovation Award
Conferred for seminal contributions in translating multimodal brain mapping into routine neuro-oncology.
Leading High-Impact Investigations
Author of seminal articles in NEJM, Lancet Oncology, Nature Communications, Cancer Cell, and Journal of Neurosurgery.
Primary Pathologies & Surgical Referrals
Submit Cranial MRI Records to Prof. Mao's Board
Upload contrast-enhanced MRI/CT imaging and past biopsy pathology reports. Our neuro-oncology coordination team delivers an initial clinical review within 24 to 48 hours.